Healthy Aging Glossary
Key terms and concepts across the full spectrum of healthy aging — biology, physiology, and lifestyle.
All Terms
24
- AI Hallucination
- Anabolic Resistance
- BDNF (Brain-Derived Neurotrophic Factor)
- CBC (Complete Blood Count)
- Cellular Senescence
- Closed-Loop Insulin Delivery
- CMP (Comprehensive Metabolic Panel)
- Continuous Glucose Monitor (CGM)
- Cuffless Blood Pressure Monitoring
- Differential Diagnosis
- Ferritin
- Glymphatic System
- HbA1c (Hemoglobin A1c)
- hs-CRP (High-Sensitivity C-Reactive Protein)
- Inflammaging
- Insulin-to-Carb Ratio
- Large Language Model (LLM)
- Protected Health Information (PHI)
- Reference Range
- Sarcopenia
- Symptom Timeline
- Time in Range
- VO2 Max
- White Coat Hypertension
A
AI Hallucination
When an AI model states incorrect or fabricated information with the same confident tone as accurate information. In a health context, this might mean an AI invents a plausible-sounding but wrong explanation for a lab value, misstates what a marker measures, or cites a reference range that doesn't match reality. There is no built-in signal distinguishing a hallucinated answer from a correct one, which is why AI-generated health information should always be verified against a physician or a trusted medical source.
Anabolic Resistance
The reduced sensitivity of aging muscle tissue to the anabolic (muscle-building) signals triggered by protein intake and exercise. Older adults require greater amounts of dietary protein -- particularly leucine -- and a stronger exercise stimulus to achieve the same muscle protein synthesis response as younger adults. This is a key reason why protein targets and training intensity both need to be higher after 40.
B
C
CBC (Complete Blood Count)
A common blood panel that measures red blood cells, white blood cells, and platelets, broadly reflecting oxygen-carrying capacity, immune function, and clotting. AI can reasonably explain what each component measures, but interpreting an abnormal CBC in the context of your health history is a clinical task.
Cellular Senescence
A state in which a cell has permanently stopped dividing but remains metabolically active. Senescent cells accumulate throughout tissues with age. They secrete a mix of inflammatory signals called the senescence-associated secretory phenotype (SASP), which drives local tissue inflammation, disrupts neighboring cells, and contributes to the chronic low-grade inflammatory state known as inflammaging. Senescence plays protective roles in youth (wound healing, tumor suppression) but becomes harmful when cells accumulate faster than they are cleared.
Closed-Loop Insulin Delivery
Sometimes called an "artificial pancreas" system, this pairs a continuous glucose monitor with an insulin pump and an algorithm that automatically adjusts insulin delivery based on real-time glucose trends. Several systems are FDA-cleared and in real-world use, substantially reducing manual decision-making, though they still require calibration and clinical oversight rather than full autonomy.
CMP (Comprehensive Metabolic Panel)
A common blood panel covering kidney function, liver function, blood sugar, and electrolytes. It's broad by design, which is why a single flagged line usually needs the rest of the panel and your history to interpret correctly rather than being read in isolation.
Continuous Glucose Monitor (CGM)
A wearable device (Dexcom, Abbott's Libre, and similar) that measures glucose in the fluid under the skin every few minutes, rather than at a single moment like a finger-stick. The continuous stream lets AI-driven software identify patterns, project trends, and issue predictive alerts before glucose goes too high or too low.
Cuffless Blood Pressure Monitoring
A method of estimating blood pressure without an inflatable cuff, typically through pulse wave analysis or optical sensors built into a smartwatch or ring. It's more convenient than cuff-based measurement but generally carries more variability, and most cuffless features are not yet at the same clinical accuracy as a validated cuff-based monitor.
D
F
G
H
HbA1c (Hemoglobin A1c)
A blood test that reflects average blood sugar levels over roughly the past three months, used to screen for and monitor diabetes and prediabetes. Unlike a single glucose reading, HbA1c reflects a longer-term average, which is why it's often read alongside more real-time data like continuous glucose monitor time-in-range rather than in isolation.
hs-CRP (High-Sensitivity C-Reactive Protein)
A blood biomarker that measures low-level systemic inflammation. CRP is produced by the liver in response to IL-6. The high-sensitivity assay detects the small elevations relevant to chronic inflammation rather than acute infection. Values below 1 mg/L are considered low risk; 1-3 mg/L is intermediate; above 3 mg/L is associated with significantly elevated cardiovascular and all-cause mortality risk. hs-CRP is one of the most accessible and clinically useful markers of inflammaging -- available on standard panels and generally covered by insurance.
I
Inflammaging
A chronic, low-grade, sterile inflammatory state that develops and intensifies with age. Coined by researcher Claudio Franceschi in 2000. Unlike acute inflammation (which resolves), inflammaging is persistent, systemic, and driven by multiple sources including senescent cells (SASP), gut dysbiosis, visceral adipose tissue, and mitochondrial damage. Elevated inflammatory markers -- particularly IL-6, TNF-alpha, and hs-CRP -- characterize the condition. Inflammaging accelerates muscle loss, cardiovascular disease, cognitive decline, and virtually every other hallmark of aging.
Insulin-to-Carb Ratio
A personalized figure, set with a physician or diabetes educator, describing how many grams of carbohydrate one unit of insulin covers. Because it's individualized and directly affects dosing, it's the kind of number that should come from and be adjusted by a clinician, not estimated or altered based on a general-purpose AI chatbot.
L
P
R
S
Sarcopenia
The progressive, age-related loss of skeletal muscle mass, strength, and function. Sarcopenia begins as early as the 30s, accelerates after 60, and is a primary driver of frailty, falls, and functional decline in older adults. It is not inevitable -- resistance training and adequate protein intake are the two most evidence-supported interventions.
Symptom Timeline
A chronological summary of when a symptom started, how it has changed, and any patterns tied to it -- worse in the morning, better after activity, and so on. A clear symptom timeline helps a physician spot patterns faster than a scattered verbal recap, and is one of the more useful things AI can help organize before an appointment.